Niagen Bioscience, Inc. (NAGE): Operating Cash Flow
$13.50M
Year ended 2025-12-31
$5.95M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.50M | +11.5% | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | $12.11M | +70.1% | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | $7.12M | n/m | 2025-03-04, From 2023-01-01 |
| 2022-12-31 | -$15.10M | n/m | 2024-03-06, From 2022-01-01 |
| 2021-12-31 | -$24.16M | n/m | 2023-03-08, From 2021-01-01 |
| 2020-12-31 | -$10.60M | n/m | 2022-03-14, From 2020-01-01 |
| 2019-12-31 | -$20.44M | n/m | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | -$20.91M | n/m | 2020-03-10, From 2017-12-31 |
| 2017-12-30 | -$9.80M | n/m | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | -$2.94M | n/m | 2018-03-15, From 2016-01-03 |
| 2016-01-02, Fiscal 2015 | -$2.11M | n/m | 2018-03-15, From 2015-01-04 |
| 2015-01-03, Fiscal 2014 | -$2.58M | n/m | 2017-03-16, From 2013-12-29 |
| 2013-12-28 | -$3.91M | n/m | 2016-03-17, From 2012-12-30 |
| 2012-12-29 | -$10.12M | n/m | 2014-03-27, From 2012-01-01 |
| 2011-12-31 | -$4.10M | n/m | 2013-03-29, From 2011-01-02 |
| 2011-01-01, Fiscal 2010 | -$2.66M | n/a | 2012-03-15, From 2010-01-03 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | 2025-12-31 | $13.50M | +11.5% |
| Natural Alternatives International Inc (NAII) | 2026-06-30 | -$8.92M | n/m |
| Cronos Group Inc. (CRON) | 2025-12-31 | $25.87M | +37.3% |
| Mannatech Inc (MTEX) | 2025-12-31 | -$2.96M | n/m |
| Marimed Inc. (MRMD) | 2025-12-31 | $7.70M | +13.4% |
| Glass House Brands Inc. (GLAS) | 2025-12-31 | $11.45M | -59.7% |
| biote Corp. (BTMD) | 2025-12-31 | $35.19M | -22.2% |
| Fitlife Brands, Inc. (FTLF) | 2025-12-31 | $7.44M | -22.6% |
| Jushi Holdings Inc. (JUSH) | 2025-12-31 | $17.73M | -17.8% |
Compare NAGE, NAII, CRON, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗